Press Releases
CRN Responds to FDA Consumer Update on Bodybuilding Supplements
CRN issued the following statement in response to a consumer update published yesterday by the U.S. Food & Drug Administration (FDA), “Caution: Bodybuilding Products Can Be Risky.”
Journal Review Mischaracterizes Majority of Dietary Supplement Products
CRN today issued the following statement in response to a recently published review in the Journal of Clinical Pharmacology, “Continued Risk of Dietary Supplements Adulterated With Approved and Unapproved Drugs: Assessment of the US Food and Drug Administration's Tainted Supplements Database 2007 Through 2021.”
Durbin, Braun Introduce Legislation to Improve Safety and Ensure Transparency of Dietary Supplement Industry
U.S. Senate Majority Whip Dick Durbin (D-IL) and U.S. Senator Mike Braun (R-IN) introduced the Dietary Supplement Listing Act of 2022, bipartisan legislation to require dietary supplement manufacturers to list their products with the Food and Drug Administration (FDA).